Niek Verweij is an executive director at Regeneron with 11 years of experience translating genetic epidemiology into therapeutic target discovery across cardiovascular, muscle, and metabolic disease areas. He blends deep academic training—a PhD in Medicine from University of Groningen and postdoctoral work at Harvard/MGH and MIT—with industry leadership roles at Regeneron and Genomics plc, driving large-scale data analysis to support preclinical through late-stage clinical teams. Known for bridging bench and bioinformatic inference, he has steered multidisciplinary programs that convert population genetics signals into actionable drug hypotheses. Based in New York, he pairs rigorous statistical and machine-learning exposure (including specialized training in Reykjavik) with hands-on biotech development, a mix that helps move complex genomics insights toward measurable clinical impact.
11 years of coding experience
15 years of employment as a software developer
Mathematics and Statistics, Mathematics and Statistics at Machine learning summer school, Reykjavík
Doctor of Philosophy (PhD) Medicine Cardiology dept., Doctor of Philosophy (PhD) Medicine Cardiology dept. at University of Groningen
Creates dichotomous phenotypes for UKbio using all available data (ICD/oper/medication/self reports/age of diagnosis/visit-dates etc). The current output includes variables on history, study visit, future, time-to-first-event. happy to help. Mail@niekverweij.com.
Contributions:50 commits, 2 PRs, 53 pushes in 2 years 7 months
Contributions:5 commits, 31 pushes, 1 branch in 6 days
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.